H¿agen-Dazs Chocolate Chocolate Chip Ice Cream, 14 oz, UPC of 74570-08400
⚠ Critical Alert — Stop Using Immediately
This product has been flagged with severe risks (undeclared allergen). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2191-2014.
Nestle is recalling the H¿agen-Dazs Chocolate Chocolate Chip Ice Cream because it was mislabeled and the ingredient statement does not identify peanuts. The affected products are labeled as H¿agen-Dazs Chocolate Chocolate Chip Ice Cream, and the lids are labeled as H¿agen-Dazs Chocolate Peanut Butter. These mismatched packages contain Chocolate Peanut Butter ice cream, and the ingredient stateme
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2191-2014.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Nestle or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2191-2014.
Nestle
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Nestle Recall FAQ
Nestle is the subject of a dairy safety report: H¿agen-Dazs Chocolate Chocolate Chip Ice Cream, 14 oz, UPC of 74570-08400. The notice was published on June 27, 2014 by the U.S. Food and Drug Administration (FDA). Approximately 1,260 units are potentially affected.